Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of CRx-191 to Assess Activity in Plaque Psoriasis

This study has been completed.
Bioskin GmbH
Information provided by:
Zalicus Identifier:
First received: November 12, 2007
Last updated: September 24, 2008
Last verified: December 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)